Clinical and genetic characteristics of children with sodium taurocholate cotransporting poly-peptide deficiency - Summary - MDSpire

Clinical and genetic characteristics of children with sodium taurocholate cotransporting poly-peptide deficiency

  • By

  • Lina Du

  • Mengyao Zhou

  • Jing Yang

  • Min Du

  • Maolin Jiang

  • Lijing Xiong

  • June 10, 2026

  • 0 min

Share

Objective:

To analyze the clinical features, genetic spectrum, and natural history of sodium taurocholate cotransporting polypeptide deficiency (NTCPD) in a pediatric cohort, highlighting its clinical significance.

Approach:
    Key Findings:
    • Patients in the jaundice group were significantly younger than those in the IH group (p = 0.003).
    • Jaundice group exhibited predominantly indirect hyperbilirubinemia and elevated γ-glutamyl transferase (γ-GT) levels (p = 0.001).
    • All patients normalized liver function parameters during follow-up.
    • The homozygous c.800C > T (p.Ser267Phe) variant was the most prevalent (14/19).
    • Four novel variants were identified: c.101T > C, c.551delT, c.896T > C, and c.654_674dup.
    Interpretation:

    The study confirms the predominance of the c.800C > T mutation in Chinese children with NTCPD, revealing phenotypic heterogeneity and generally favorable outcomes, which may have implications for clinical management.

    Limitations:
    • Study conducted at a single center, limiting generalizability and introducing potential biases.
    • Small sample size may affect the robustness of findings.
    Conclusion:

    The study expands the clinical data on NTCPD in children, emphasizing the need for future multi-center collaborations and extended follow-up to elucidate genotype-phenotype correlations and their clinical implications.

Original Source(s)

Related Content